ArticleFrontiers in medicine2026
Lipid profile-based prognostic nomograms for obstructive colorectal cancer: multi-cohort development and validation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with obstructive colorectal cancer (OCRC) have poor prognosis, and conventional prognostic tools such as TNM staging alone are insufficient for accurate assessment; thus, this study aimed to develop and validate nomograms for predicting overall survival (OS) and disease-free survival (DFS) in OCRC patients. A total of 1,650 eligible colorectal cancer patients were enrolled, including 1,520 from Center A (randomly split 6:4 into training and internal validation cohorts) and 130 from Center B as the external validation cohort; clinicopathological and lipid profile data were collected retrospectively, independent prognostic factors were identified via univariate and multivariate Cox regression, and OS/DFS nomograms were constructed and evaluated using ROC curves, C-index, calibration curves, and DCA. The OS nomogram included 8 factors with 1-, 3-, 5-year AUCs of 0.761-0.793 (training), 0.759-0.788 (internal validation), and 0.723-0.856 (external validation), while the DFS nomogram included 6 factors with corresponding AUCs of 0.777-0.822, 0.750-0.841, and 0.775-0.820, and all evaluations confirmed excellent model performance. In conclusion, two nomograms incorporating lipid and clinicopathological factors were developed and validated, which effectively predict OS and DFS in OCRC patients with good discrimination, calibration, and clinical utility, providing new tools for individualized risk prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.